Breast Cancer Statistics in Korea, 2018

다국어 초록 (Multilingual Abstract)

Breast cancer is the most common malignancy in Korean women, and its incidence continues to increase. The Korean Breast Cancer Society (KBCS) established a nationwide breast cancer database through its online enrollment program in 1996. This study aimed to analyze the clinical characteristics of breast cancer in Korea, and to assess the pattern of changes in breast cancer management in 2018. We analyzed the KBCS and Korea Central Cancer Registry (KCCR) databases in 2018. In 2018, 28,157 patients were newly diagnosed with breast cancer, of whom 4,510 had noninvasive breast cancer and 23,647 had invasive breast cancer. The age-standardized rate of breast cancer in 2018 was 79.0 per 100,000 women (65.6 invasive, 13.4 noninvasive). The median age of female patients diagnosed with breast cancer in 2018 was 52 years, and the incidence of breast cancer was the highest in the 40–49-years age group (9,432 patients, 33.6%). The proportion of patients with stage 0 and stage I breast cancer continued to increase, accounting for 63.8% of cases, and breast-conserving surgery was performed more often than mastectomy (66.2% vs. 33.0%). The most common subtypes of breast cancer were hormone receptor [HR]-positive and human epidermal growth factor receptor-2 (HER2)-negative types (65.9% of cases), while the HR-negative and HER2-positive types accounted for 9.2% of cases. According to the KCCR data, from 2014 to 2018, the 5-year relative survival rate of patients with breast cancer was 93.3%, which was 14.0% higher than that from 1993 to 1995 (79.3%). The clinical characteristics of breast cancer in Korea have been changing, and national databases can improve our understanding of the disease characteristics of Korean women. Therefore, updating the KBCS registry is important for the effective management of breast cancer in Korea.

참고문헌 (Reference)

1 International statistical classification of diseases and related health problems (ICD), "World Health Organization"

2 하경화, "Trends in the Diabetes Epidemic in Korea" 대한내분비학회 30 (30): 142-146, 2015

3 서민아, "Trends in Cancer Screening Rates among Korean Men and Women: Results of the Korean National Cancer Screening Survey, 2004-2013" 대한암학회 48 (48): 1-10, 2016

4 Henson DE, "The relative survival rate" 76 : 1687-1688, 1995

5 민선영, "The Basic Facts of Korean Breast Cancer in 2013: Results of a Nationwide Survey and Breast Cancer Registry Database" 한국유방암학회 19 (19): 1-7, 2016

6 "Statistics Korea"

7 Boughey JC, "Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer : the ACOSOG Z1071(Alliance)clinical trial" 310 : 1455-1461, 2013

8 "RxPONDER clinical trial key findings presented at San Antonio Breast Cancer Symposium"

9 Nitz U, "Reducing chemotherapy use in clinically high-risk, genomically low-risk pN0 and pN1 early breast cancer patients: five-year data from the prospective, randomised phase 3 West German Study Group (WSG) PlanB trial" 165 : 573-583, 2017

10 Kim HJ, "Permutation tests for joinpoint regression with applications to cancer rates" 19 : 335-351, 2000

11 "National Cancer Information Center"

12 정용식, "Nation-Wide Korean Breast Cancer Data from 2008 Using the Breast Cancer Registration Program" 한국유방암학회 14 (14): 229-236, 2011

13 Yoo KY, "Lifestyle, genetic susceptibility and future trends of breast cancer in Korea" 7 : 679-682, 2006

14 Sohn K, "Improvement in the biological standard of living in 20th century Korea : evidence from age at menarche" 29 : e22882-, 2017

15 Park CY, "Evaluation of menopausal hormone therapy use in Korea(2002-2013) : a nationwide cohort study" 146 : 57-62, 2021

16 Yamashita H, "Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis" 22 : 1318-1325, 2011

17 Choi KS, "Effect of mammography screening on stage at breast cancer diagnosis : results from the Korea National Cancer Screening Program" 8 : 8882-, 2018

18 Giuliano AE, "Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis : the ACOSOG Z0011(Alliance)randomized clinical trial" 318 : 918-926, 2017

19 Kim Y, "Dose-dependent protective effect of breastfeeding against breast cancer among ever-lactated women in Korea" 16 : 124-129, 2007

20 Mizukoshi MM, "Comparative analysis of breast cancer incidence rates between Australia and Japan : screening target implications" 21 : 2123-2129, 2020

21 "Cancer today: data visualization tools for exploring the global cancer burden in 2020" International Agency for Research on Cancer

22 "Cancer staging system" American College of Surgeons

23 Segi M, "Cancer mortality for selected sites in 24 countries (1950–1957)" Department of Public Health, Tohoku University School of Medicine 1960

24 홍세리, "Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017" 대한암학회 52 (52): 335-350, 2020

25 DeSantis CE, "Breast cancer statistics, 2019" 69 : 438-451, 2019

26 DeSantis CE, "Breast cancer statistics, 2017, racial disparity in mortality by state" 67 : 439-448, 2017

27 강상율, "Breast Cancer Statistics in Korea in 2017: Data from a Breast Cancer Registry" 한국유방암학회 23 (23): 115-128, 2020

28 강상율, "Basic Findings Regarding Breast Cancer in Korea in 2015: Data from a Breast Cancer Registry" 한국유방암학회 21 (21): 1-10, 2018

29 Yang XR, "Associations of breast cancer risk factors with tumor subtypes : a pooled analysis from the Breast Cancer Association Consortium studies" 103 : 250-263, 2011

30 Park CY, "Age at natural menopause in Koreans : secular trends and influences thereon" 25 : 423-429, 2018